CRISIL has downgraded Archean Chemical Industries' long-term bank facility rating to CRISIL A-/Stable from A/Negative, citing lower bromine sales and rising costs in its semiconductor project. While liquidity remains strong, shareholders should watch for project delays and increased debt levels.
Archean Chemical Industries Credit Rating Downgraded to CRISIL A-/Stable
Long-term bank facility rating cut to CRISIL A-/Stable from CRISIL A/Negative; total rated debt increased to Rs 1,531 crore.
Reader Takeaway: Downgrade reflects project cost overruns and softer core business, though liquidity support remains a key stabilizer.
What just happened
CRISIL Ratings has downgraded the long-term bank facilities of Archean Chemical Industries Ltd (ACIL) from 'CRISIL A/Negative' to 'CRISIL A-/Stable'. The total amount of rated debt has been enhanced significantly to Rs 1,531 crore, up from Rs 265 crore previously, reflecting increased financing requirements.
Why this matters
The rating action highlights a moderation in the company's business risk profile. Operational challenges, specifically lower-than-anticipated bromine sales volumes and struggles within the mud chemical business, have constrained operating profits. Simultaneously, the company's ambitious silicon carbide (SiC) semiconductor project has seen costs surge from an estimated Rs 2,100 crore to approximately Rs 2,500 crore, necessitating higher debt intake.
The backstory
Archean Chemical reported a net profit of Rs 105 crore in FY2026, down from Rs 162 crore in FY2025. The current fiscal period has continued to face headwinds, with moderation in Q1 FY2027 performance. The company is currently heavily reliant on its internal cash generation, estimated at Rs 200-250 crore annually, to meet debt obligations and regular maintenance capital expenditure.
Risks to watch
Investors should monitor the execution risks of the SiC semiconductor project, as further cost overruns or timeline delays could further weaken debt protection metrics. Additionally, CRISIL noted that promoter share pledging has reached 24.5% as of June 2026, which remains a factor for governance monitoring. The firm also faces inherent volatility in product realization and geographic concentration risks linked to its single-location manufacturing setup.
What to track next
The primary focus for stakeholders will be the management’s ability to restore operating margins in the core bromine and salt segments, the timely execution of the semiconductor facility, and any shifts in the debt-to-EBITDA ratio as the new project moves toward stabilization.